{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:57:33Z","timestamp":1790989053578,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013105","name":"Shanghai Institute of Materia Medica Rising-Star Program","doi-asserted-by":"publisher","award":["22QA1407100"],"award-info":[{"award-number":["22QA1407100"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007925","name":"Huazhong Agricultural University","doi-asserted-by":"publisher","award":["2662024SYPY001"],"award-info":[{"award-number":["2662024SYPY001"]}],"id":[{"id":"10.13039\/501100007925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270777"],"award-info":[{"award-number":["32270777"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103260"],"award-info":[{"award-number":["82103260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bbadis.2026.168416","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:41:37Z","timestamp":1786981297000},"page":"168416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neddylation-triggered ubiquitination and proteasomal degradation of HELLS inhibits prostate cancer growth via genomic instability"],"prefix":"10.1016","volume":"1873","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuorong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2026.168416_bb0005","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1002\/pros.24354","article-title":"Future directions for precision oncology in prostate cancer","volume":"82","author":"Mizuno","year":"2022","journal-title":"Prostate"},{"key":"10.1016\/j.bbadis.2026.168416_bb0010","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202401480R","article-title":"Osteoblast-derived exosomal miR-140-3p targets ACER2 and increases the progression of prostate cancer via the AKT\/mTOR pathway-mediated inhibition of autophagy","volume":"38","author":"Liu","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2026.168416_bb0015","doi-asserted-by":"crossref","first-page":"13519","DOI":"10.3390\/ijms222413519","article-title":"An insight on novel molecular pathways in metastatic prostate cancer: a focus on DDR, MSI and AKT","volume":"22","author":"Mollica","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2026.168416_bb0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41698-025-00904-x","article-title":"FOXA1-dependent NSUN2 facilitates the advancement of prostate cancer by preserving TRIM28 mRNA stability in a m5C-dependent manner","volume":"9","author":"Wang","year":"2025","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.bbadis.2026.168416_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030546","article-title":"Bone targeting agents in patients with metastatic prostate cancer: state of the art","volume":"13","author":"Mollica","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbadis.2026.168416_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41391-025-01067-3","article-title":"Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study","author":"B\u00fcttner","year":"2026","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.bbadis.2026.168416_bb0035","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.euo.2024.11.005","article-title":"Apalutamide in metastatic castration-sensitive prostate cancer: results from the multicenter real-world ARON-3 study","volume":"8","author":"Santoni","year":"2025","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.bbadis.2026.168416_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2026.05.010","article-title":"Doublet versus triplet therapy in high-volume metastatic hormone-sensitive prostate cancer patients with bone metastases: results from the ARON-3 study","author":"Mandel","year":"2026","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.bbadis.2026.168416_bb0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/17425255.2022.2072727","article-title":"Incidence of grade 3\u20134 adverse events, dose reduction, and treatment discontinuation in castration-resistant prostate cancer patients receiving PARP inhibitors: a meta-analysis","volume":"18","author":"Rizzo","year":"2022","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bbadis.2026.168416_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1544882","article-title":"The application of emerging immunotherapy in the treatment of prostate cancer: progress, dilemma and promise","volume":"16","author":"Che","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2026.168416_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/modpathol.2017.166","article-title":"The genomics of prostate cancer: emerging understanding with technologic advances","volume":"31","author":"Rubin","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbadis.2026.168416_bb0060","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41416-021-01543-2","article-title":"Lymphoid-specific helicase in epigenetics, DNA repair and cancer","volume":"126","author":"Chen","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbadis.2026.168416_bb0065","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3233\/CBM-230073","article-title":"Immunological function and prognostic value of lymphoid-specific helicase in liver hepatocellular carcinoma","volume":"38","author":"Fang","year":"2023","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.bbadis.2026.168416_bb0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/epigenomes1010002","article-title":"Helicase lymphoid-specific enzyme contributes to the maintenance of methylation of SST1 pericentromeric repeats that are frequently demethylated in colon cancer and associate with genomic damage","volume":"1","author":"Samuelsson","year":"2016","journal-title":"Epigenomes"},{"key":"10.1016\/j.bbadis.2026.168416_bb0075","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1038\/s41467-021-23809-2","article-title":"The epigenetic regulator LSH maintains fork protection and genomic stability via MacroH2A deposition and RAD51 filament formation","volume":"12","author":"Xu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2026.168416_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169313","article-title":"The chromatin remodeler HELLS: a new regulator in DNA repair, genome maintenance, and cancer","volume":"23","author":"Peixoto","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2026.168416_bb0085","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/cam4.3627","article-title":"Hells, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and sensitizes to cisplatin by reexpressing the tumor suppressor TGFBR3","volume":"10","author":"Hou","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbadis.2026.168416_bb0090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41419-025-07589-x","article-title":"HELLS controls mitochondrial dynamics and genome stability in liver cancer by collusion with MIEF1","volume":"16","author":"Choi","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2026.168416_bb0095","doi-asserted-by":"crossref","first-page":"10153","DOI":"10.2147\/OTT.S223668","article-title":"Downregulation of the helicase lymphoid-specific (HELLS) gene impairs cell proliferation and induces cell cycle arrest in colorectal cancer cells","volume":"12","author":"Liu","year":"2019","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.bbadis.2026.168416_bb0100","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/hep.30414","article-title":"HELLS regulates chromatin remodeling and epigenetic silencing of multiple tumor suppressor genes in human hepatocellular carcinoma","volume":"69","author":"Law","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2026.168416_bb0105","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126140","article-title":"Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC","volume":"4","author":"Zhang","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbadis.2026.168416_bb0110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41419-021-03425-0","article-title":"The DNA-helicase HELLS drives ALK\u2212 ALCL proliferation by the transcriptional control of a cytokinesis-related program","volume":"12","author":"Tameni","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2026.168416_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117053","article-title":"FATS alleviates ulcerative colitis by inhibiting M1 macrophage polarization and aerobic glycolysis through promoting the ubiquitination-mediated degradation of HIF-1\u03b1","volume":"240","author":"Han","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2026.168416_bb0120","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.7150\/ijbs.98907","article-title":"NDR1\/FBXO11 promotes phosphorylation-mediated ubiquitination of \u03b2-catenin to suppress metastasis in prostate cancer","volume":"20","author":"Xuan","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbadis.2026.168416_bb0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.sbi.2020.10.007","article-title":"Nedd8 and ubiquitin ligation by cullin-RING E3 ligases","volume":"67","author":"Baek","year":"2021","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bbadis.2026.168416_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13045-023-01485-7","article-title":"Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions","volume":"16","author":"Fu","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbadis.2026.168416_bb0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41420-023-01337-w","article-title":"NEDD8-conjugating enzyme E2s: critical targets for cancer therapy","volume":"9","author":"Zhou","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbadis.2026.168416_bb0140","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1182\/blood-2023-185481","article-title":"Phase 1b\/2 study of escalating doses of the NEDD8 activating enzyme inhibitor Pevonedistat administered in combination with standard induction therapy (Cytarabine and Idarubicin) in newly diagnosed high risk acute myeloid leukemia","volume":"142","author":"Feliciano","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2026.168416_bb0145","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1038\/s41467-020-18009-3","article-title":"Helicase LSH\/Hells regulates kinetochore function, histone H3\/Thr3 phosphorylation and centromere transcription during oocyte meiosis","volume":"11","author":"Baumann","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2026.168416_bb0150","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/s41418-020-00689-5","article-title":"CRL4DCAF8 dependent opposing stability control over the chromatin remodeler LSH orchestrates epigenetic dynamics in ferroptosis","volume":"28","author":"Huang","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2026.168416_bb0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.seminoncol.2023.09.005","article-title":"PARP inhibitors: a review of the pharmacology, pharmacokinetics, and pharmacogenetics","volume":"51","author":"Zeng","year":"2024","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bbadis.2026.168416_bb0160","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2147\/OTT.S426923","article-title":"Inhibition of ATM with KU-55933 sensitizes endometrial cancer cell lines to olaparib","volume":"16","author":"Zhang","year":"2023","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.bbadis.2026.168416_bb0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41392-024-01800-9","article-title":"Protein neddylation and its role in health and diseases","volume":"9","author":"Zhang","year":"2024","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2026.168416_bb0170","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/procel\/pwad045","article-title":"The ubiquitin codes in cellular stress responses","volume":"15","author":"Sheng","year":"2024","journal-title":"Protein Cell"},{"key":"10.1016\/j.bbadis.2026.168416_bb0175","doi-asserted-by":"crossref","first-page":"51798","DOI":"10.1109\/ACCESS.2023.3279498","article-title":"DTL-NeddSite: a deep-transfer learning architecture for prediction of lysine neddylation sites","volume":"11","author":"Xu","year":"2023","journal-title":"IEEE Access"},{"key":"10.1016\/j.bbadis.2026.168416_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108300","article-title":"A predictive chromatin architecture nexus regulates transcription and DNA damage repair","volume":"301","author":"Bhat","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2026.168416_bb0185","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.stem.2010.12.009","article-title":"\u0394Np63\u03b1 is an oncogene that targets chromatin remodeler Lsh to drive skin stem cell proliferation and tumorigenesis","volume":"8","author":"Keyes","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbadis.2026.168416_bb0190","doi-asserted-by":"crossref","first-page":"132","DOI":"10.7150\/thno.17032","article-title":"Chromatin remodeling factor LSH is upregulated by the LRP6-GSK3\u03b2-E2F1 Axis linking reversely with survival in gliomas","volume":"7","author":"Xiao","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.bbadis.2026.168416_bb0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41392-020-00249-w","article-title":"The cross-talk between methylation and phosphorylation in lymphoid-specific helicase drives cancer stem-like properties","volume":"5","author":"Liu","year":"2020","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2026.168416_bb0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3892\/ijo.2023.5513","article-title":"Targeting neddylation as a novel approach to lung cancer treatment (review)","volume":"62","author":"Tian","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbadis.2026.168416_bb0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41422-020-00443-z","article-title":"Neddylation of PTEN regulates its nuclear import and promotes tumor development","volume":"31","author":"Xie","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.bbadis.2026.168416_bb0210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/cells13010029","article-title":"Targeting the ubiquitin\u2013proteasome system and recent advances in cancer therapy","volume":"13","author":"Spano","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2026.168416_bb0215","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.intimp.2010.12.007","article-title":"Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor","volume":"11","author":"Qi","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbadis.2026.168416_bb0220","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1093\/nar\/gkae239","article-title":"HELLS regulates transcription in T-cell lymphomas by reducing unscheduled R-loops and by facilitating RNAPII progression","volume":"52","author":"Tameni","year":"2024","journal-title":"Nucleic Acids Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926002796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926002796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:24:58Z","timestamp":1790987098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926002796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S0925443926002796"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168416","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neddylation-triggered ubiquitination and proteasomal degradation of HELLS inhibits prostate cancer growth via genomic instability","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168416"}}